NEXALIN TECHNOLOGY, INC. Financials Nexalin Technology, Inc.
Equities
NXL
US65345B2016
Advanced Medical Equipment & Technology
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.16 USD | +0.86% |
|
-14.71% | +186.56% |
| May. 10 | Nexalin Technology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 25 | Nexalin Technology Regains Compliance With Nasdaq Listing Requirement | MT |
Valuation
| Fiscal Period: December | 2022 | 2023 |
|---|---|---|
| Capitalization 1 | 5.453 | 3.01 |
| Enterprise Value (EV) 1 | -0.786 | 0.0663 |
| P/E ratio | -2.46 x | -0.64 x |
| Yield | - | - |
| Capitalization / Revenue | 4.13 x | 27.2 x |
| EV / Revenue | -0.59 x | 0.6 x |
| EV / EBITDA | 0.43 x | -0.01 x |
| EV / FCF | 479,376 x | -31,540 x |
| FCF Yield | 0% | -0% |
| Price to Book | 1 x | 0.94 x |
| Nbr of stocks (in thousands) | 7,280 | 7,437 |
| Reference price 2 | 0.7490 | 0.4048 |
| Announcement Date | 3/27/23 | 3/27/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Net sales 1 | 0.2074 | 0.2429 | 0.1441 | 1.321 | 0.1107 |
| EBITDA 1 | -1.466 | -3.258 | -6.018 | -1.832 | -5.692 |
| EBIT 1 | -1.466 | -3.258 | -6.019 | -1.833 | -5.696 |
| Operating Margin | -706.98% | -1,341.38% | -4,177.7% | -138.72% | -5,143.48% |
| Earnings before Tax (EBT) 1 | -5.021 | -3.403 | -6.078 | -1.698 | -4.649 |
| Net income 1 | -5.021 | -3.403 | -6.078 | -1.698 | -4.649 |
| Net margin | -2,421.22% | -1,401.11% | -4,218.93% | -128.49% | -4,197.56% |
| EPS 2 | -1.649 | -0.9498 | -1.428 | -0.3047 | -0.6319 |
| Free Cash Flow | - | 0.4094 | 1.216 | -1.64 | -2.103 |
| FCF margin | - | 168.53% | 843.98% | -124.08% | -1,899.28% |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 1/4/22 | 1/4/22 | 4/8/22 | 3/27/23 | 3/27/24 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Net Debt 1 | 0.76 | 0.65 | 0.19 | - | - |
| Net Cash position 1 | - | - | - | 6.24 | 2.94 |
| Leverage (Debt/EBITDA) | -0.5208 x | -0.1988 x | -0.0313 x | - | - |
| Free Cash Flow | - | 0.41 | 1.22 | -1.64 | -2.1 |
| ROE (net income / shareholders' equity) | - | 246% | 371% | -89.4% | -107% |
| ROA (Net income/ Total Assets) | - | -1,763% | -863% | -28% | -64.4% |
| Assets 1 | - | 0.193 | 0.7046 | 6.066 | 7.223 |
| Book Value Per Share 2 | -0.3900 | -0.4300 | -0.3400 | 0.7500 | 0.4300 |
| Cash Flow per Share 2 | 0.0200 | 0.0200 | 0.1400 | 0.0200 | 0.0800 |
| Capex | - | 0 | - | - | - |
| Capex / Sales | - | 0.27% | - | - | - |
| Announcement Date | 1/4/22 | 1/4/22 | 4/8/22 | 3/27/23 | 3/27/24 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +186.56% | 8.55M | |
| +12.11% | 225B | |
| +15.79% | 197B | |
| +19.20% | 143B | |
| +31.27% | 111B | |
| +3.08% | 64.72B | |
| +19.59% | 54.44B | |
| +5.12% | 51.06B | |
| +10.97% | 45.03B | |
| +4.91% | 37.4B |
- Stock Market
- Equities
- NXL Stock
- Financials Nexalin Technology, Inc.